Klibanski A - Search Results

1

Receptor internalization-independent activation of Smad2 in activin signaling.

Zhou Y, Scolavino S, Funderburk SF, Ficociello LF, Zhang X, Klibanski A. Zhou Y, et al. Among authors: klibanski a. Mol Endocrinol. 2004 Jul;18(7):1818-26. doi: 10.1210/me.2004-0079. Epub 2004 Apr 15. Mol Endocrinol. 2004. PMID: 15087470

2

Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.

Alexander JM, Bikkal HA, Zervas NT, Laws ER Jr, Klibanski A. Alexander JM, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 1996 Feb;81(2):783-90. doi: 10.1210/jcem.81.2.8636304. J Clin Endocrinol Metab. 1996. PMID: 8636304

3

Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.

D'Abronzo FH, Swearingen B, Klibanski A, Alexander JM. D'Abronzo FH, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 1999 May;84(5):1716-21. doi: 10.1210/jcem.84.5.5704. J Clin Endocrinol Metab. 1999. PMID: 10323406

4

Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.

Zhang X, Danila DC, Katai M, Swearingen B, Klibanski A. Zhang X, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 1999 Dec;84(12):4652-5. doi: 10.1210/jcem.84.12.6191. J Clin Endocrinol Metab. 1999. PMID: 10599733

5

Activin effects on neoplastic proliferation of human pituitary tumors.

Danila DC, Inder WJ, Zhang X, Alexander JM, Swearingen B, Hedley-Whyte ET, Klibanski A. Danila DC, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 2000 Mar;85(3):1009-15. doi: 10.1210/jcem.85.3.6473. J Clin Endocrinol Metab. 2000. PMID: 10720031

6

A human pituitary tumor-derived folliculostellate cell line.

Danila DC, Zhang X, Zhou Y, Dickersin GR, Fletcher JA, Hedley-Whyte ET, Selig MK, Johnson SR, Klibanski A. Danila DC, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 2000 Mar;85(3):1180-7. doi: 10.1210/jcem.85.3.6424. J Clin Endocrinol Metab. 2000. PMID: 10720059

7

Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.

Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X, Klibanski A. Zhou Y, et al. Among authors: klibanski a. Mol Endocrinol. 2000 Dec;14(12):2066-75. doi: 10.1210/mend.14.12.0570. Mol Endocrinol. 2000. PMID: 11117535

8

Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.

Danila DC, Haidar JN, Zhang X, Katznelson L, Culler MD, Klibanski A. Danila DC, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 2001 Jul;86(7):2976-81. doi: 10.1210/jcem.86.7.7620. J Clin Endocrinol Metab. 2001. PMID: 11443154

9

Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.

Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A. Zhang X, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 2002 Mar;87(3):1262-7. doi: 10.1210/jcem.87.3.8315. J Clin Endocrinol Metab. 2002. PMID: 11889197

10

Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.

Danila DC, Zhang X, Zhou Y, Haidar JN, Klibanski A. Danila DC, et al. Among authors: klibanski a. J Clin Endocrinol Metab. 2002 Oct;87(10):4741-6. doi: 10.1210/jc.2002-020527. J Clin Endocrinol Metab. 2002. PMID: 12364468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters